Global Scoliosis Treatment Market Research Report: Information by Disease (Infantile Idiopathic Scoliosis and Adolescent Idiopathic Scoliosis), Product (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Thoracolumbosacral Orthosis (TLSO) and Lumbosacral Orthosis (LSO)), Distribution Channel (Hospitals & Clinics, Retail Pharmacies and Online Pharmacies) an
(2)
DALLAS, TX / ACCESSWIRE / February 16, 2021 / According to new report added in Report Banana offerings, there are significant money making opportunities available in the regenerative medicine market. Companies planning to enter this market need to prepare and differentiate to maximize their return on investment.
In terms of opportunities, the regenerative medicine market is expected to grow from $5,444 million in 2016, to $39,325 million by 2023; it is expected to grow at a CAGR of 32.2% during the forecast period.
Regenerative medicines repair, replace, and regenerate tissues and organs affected due to injury, disease, or natural ageing process. These medicines help restore the functionality of cells & tissues and are applicable in numerous degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Researchers focus on developing technologies based on biologics, genes, somatic as well as stem cells. Stem cells are capa
The Regenerative Medicine Market is Expected to Reach $39,325 Million by 2023 with CAGR of 32 2% tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has selected Vafa Jamali as chief executive officer of NewCo, the spine and dental businesses of Zimmer Biomet that will spin off into an independe
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14. 2% from 2020 to 2027.
Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore, maintain, or improve tissue function. In addition, for this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs.
The tissue engineering market is anticipated to grow significantly during the forecast period, owing to increase in prevalence of chronic diseases & trauma emergencies, The rise in awareness related to tissue engineering, and potential pipeline products. Furthermore, growth in number of R&D activities with The rise in awareness of tissue engineering in emerging economies are expected to